Molecular signatures of bone metastatic breast and prostate cancer

Molecular signatures of bone metastatic breast and prostate cancer

Bibliographic Details
Main Authors:	F. La Manna, M. De Menna, E. Rodrigues Sousa, M. De Filippo, P. Kloen, L. Beimers, G.N. Thalmann, M. Kruithof-De Julio
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320338258

Similar Items

Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
by: Federico La Manna, et al.
Published: (2020-06-01)

Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
by: Federico La Manna, et al.
Published: (2021-02-01)

Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer
by: CA Rentsch, et al.
Published: (2009-04-01)

The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
by: Francesco Bonollo, et al.
Published: (2020-07-01)

Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
by: Sofia Karkampouna, et al.
Published: (2020-12-01)

Personalised organoid drug treatment and therapy resistance characterization based on novel BRCA2 prostate cancer xenograft of SPOP-like phenotype and microsatellite instability
by: S. Karkampouna, et al.
Published: (2020-07-01)

Stress in Metastatic Breast Cancer: To the Bone and Beyond
by: Catarina Lourenço, et al.
Published: (2022-04-01)

A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles
by: Elisa Rodrigues Sousa, et al.
Published: (2020-06-01)

Epiregulin expression and secretion is increased in castration-resistant prostate cancer
by: Marc Wiesehöfer, et al.
Published: (2023-03-01)

Animal models of bone metastatic prostate cancer
by: Jong Hyun Tae, et al.
Published: (2023-05-01)

Efficacy of 153Sm-EDTMP on Bone Pain Palliation in Metastatic Patients: Breast and Prostate Cancers
by: Mojtaba Rokni, et al.
Published: (2023-06-01)

Characterization of a rat model of metastatic prostate cancer bone pain
by: Paolo Donato De Ciantis, et al.
Published: (2010-11-01)

Association of adenosine signaling gene signature with estrogen receptor-positive breast and prostate cancer bone metastasis
by: Daniel Brian Shropshire, et al.
Published: (2022-09-01)

Endothelial Cells as Precursors for Osteoblasts in the Metastatic Prostate Cancer Bone
by: Ana E. Paiva, et al.
Published: (2017-11-01)

Osteoid cell-derived chemokines drive bone-metastatic prostate cancer
by: Catherine S. Johnson, et al.
Published: (2023-03-01)

Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion
by: Yugang Wang, et al.
Published: (2020-04-01)

An ex vivo Tissue Culture Model for the Assessment of Individualized Drug Responses in Prostate and Bladder Cancer
by: Arjanneke F. van de Merbel, et al.
Published: (2018-10-01)

Liver uptake on bone scan for prostate cancer metastatic workup
by: Alain Mwamba Mukendi
Published: (2019-09-01)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2016-03-01)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2016-01-01)

556 Chemo-immunotherapy to treat bone-metastatic prostate cancer
by: Shreya Kumar, et al.
Published: (2021-11-01)

The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
by: Berna C Özdemir, et al.
Published: (2014-01-01)

Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patients
by: A. Beltran-Bless, et al.
Published: (2021-12-01)

Bone morphogenetic protein pathway responses and alterations of osteogenesis in metastatic prostate cancers
by: Meredith D. Provera, et al.
Published: (2023-02-01)

Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer
by: Arturo Araujo, et al.
Published: (2021-02-01)

Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids
by: Sanghee Lee, et al.
Published: (2022-03-01)

Patient-derived xenografts and organoids model therapy response in prostate cancer
by: Sofia Karkampouna, et al.
Published: (2021-02-01)

Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells
by: Elena D. Czyrnik, et al.
Published: (2023-08-01)

Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer
by: Shreya Kumar, et al.
Published: (2023-09-01)

Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
by: Veronica Mollica, et al.
Published: (2021-02-01)

Bone marrow involvement in patients with metastatic castration sensitive prostate cancer.
by: Mohammed Shahait, et al.
Published: (2022-01-01)

Metastatic Breast Cancer Recurrence after Bone Fractures
by: Nadia Obi, et al.
Published: (2022-01-01)

Metastatic prostate cancer remains incurable, why?
by: Liang Dong, et al.
Published: (2019-01-01)

Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment
by: Caterina Gianni, et al.
Published: (2022-08-01)

Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer.
by: Daichi Shigemizu, et al.
Published: (2012-02-01)

Modulation of the pre-metastatic bone niche: molecular changes mediated by bone-homing prostate cancer extracellular vesicles
by: Thomas J. Brown, et al.
Published: (2024-02-01)

Morphological Phenotyping of Organotropic Brain- and Bone-Seeking Triple Negative Metastatic Breast Tumor Cells
by: Ariana Joy L. DeCastro, et al.
Published: (2022-02-01)

A Synchronous Diagnosis of Metastatic Male Breast Cancer and Prostate Cancer
by: Leila Moosavi MD, et al.
Published: (2019-05-01)

Vascular Differences Detected by MRI for Metastatic Versus Nonmetastatic Breast and Prostate Cancer Xenografts
by: Zaver M. Bhujwalla, et al.
Published: (2001-01-01)

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned
by: Christian Thomas, et al.
Published: (2016-08-01)